Many diseases can be successfully treated in the simple environment of a cell culture dish, but to successfully treat real people, the drug agent has to take a journey through the infinitely more complex environment within our bodies and arrive, intact, inside the affected cells.
Eiger BioPharmaceuticals to focus on GLP-1 candidate, cut workforce by 25%
Eiger BioPharmaceuticals said it’s now focused on developing a GLP-1 antagonist amid a review of its business that includes laying off 25% of its employees